Patrick Rossignol

Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Andrew A. House, Christoph Wanner, Mark J. Sarnak et al. · Kidney International · 2019 · 413 citations · Full text

Evaluation of Kidney Function Throughout the Heart Failure Trajectory – A Position Statement from the Heart Failure Association of the European Society of Cardiology

Wilfried Müllens, Kevin Damman, Jeffrey M. Testani et al. · European Journal of Heart Failure · 2020 · 373 citations · Full text

Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis

Laurent Calvier, María Miana, Pascal Reboul et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2012 · 354 citations

Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial

Rajiv Agarwal, Patrick Rossignol, Alain Romero et al. · The Lancet · 2019 · 351 citations

Hypertension, Patiromer Versus Placebo, Cardiovascular Disease +10

Prognostic Value of Residual Pulmonary Congestion at Discharge Assessed by Lung Ultrasound Imaging in Heart Failure

Stefano Coiro, Patrick Rossignol, Giuseppe Ambrosio et al. · European Journal of Heart Failure · 2015 · 282 citations